---
figid: PMC4144918__nihms603842f1
figtitle: Do Mantle Cell Lymphomas have an “Achilles Heel”?
organisms:
- Homo sapiens
pmcid: PMC4144918
filename: nihms603842f1.jpg
figlink: /pmc/articles/PMC4144918/figure/F1/
number: F1
caption: BCR engagement induces a cascade of phosphorylation/activation of the pathway
  kinases (e.g. SYK, PI3Kδ, and BTK), leading to activation of the canonical NFκB
  pathway. Loss of function mutations in BIRC3 (encodes cIAP2) and TRAF2 release NIK
  from the inhibition, which leads to non-canonical NFκB pathway activation. Upon
  activation by apoptotic stimuli, the BH3-only proteins (e.g. BIM and BAD) inhibit
  the anti-apoptotic BCL-2 family members (e.g. BCL-2 and BCL-XL), thus releasing
  the pro-apoptotic members BAX and BAK and inducing apoptosis through caspase activation.
  Cyclin-D1 dimerizes with CDK4 and CDK6 to phosphorylate the Rb protein, thus releasing
  the transcription factor E2F and promoting cell cycle entry. Upon DNA damage, ATM
  activates P53 to initiate DNA repair, cell cycle inhibition, or even cell death.
  CHK1 and CHK2 kinases activate P53 while MDM2 and MDM4 E3-ubiquitin ligases inhibit
  P53. Illustration by authors.
papertitle: Do Mantle Cell Lymphomas have an “Achilles Heel”?.
reftext: Nakhle Saba, et al. Curr Opin Hematol. ;21(4):350-357.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9648517
figid_alias: PMC4144918__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4144918__F1
ndex: 0cad04c0-ded4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4144918__nihms603842f1.html
  '@type': Dataset
  description: BCR engagement induces a cascade of phosphorylation/activation of the
    pathway kinases (e.g. SYK, PI3Kδ, and BTK), leading to activation of the canonical
    NFκB pathway. Loss of function mutations in BIRC3 (encodes cIAP2) and TRAF2 release
    NIK from the inhibition, which leads to non-canonical NFκB pathway activation.
    Upon activation by apoptotic stimuli, the BH3-only proteins (e.g. BIM and BAD)
    inhibit the anti-apoptotic BCL-2 family members (e.g. BCL-2 and BCL-XL), thus
    releasing the pro-apoptotic members BAX and BAK and inducing apoptosis through
    caspase activation. Cyclin-D1 dimerizes with CDK4 and CDK6 to phosphorylate the
    Rb protein, thus releasing the transcription factor E2F and promoting cell cycle
    entry. Upon DNA damage, ATM activates P53 to initiate DNA repair, cell cycle inhibition,
    or even cell death. CHK1 and CHK2 kinases activate P53 while MDM2 and MDM4 E3-ubiquitin
    ligases inhibit P53. Illustration by authors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFRSF13C
  - BCR
  - RN7SL263P
  - CD40
  - LYN
  - TRAF3
  - SYK
  - BIRC3
  - TRAF2
  - TANK
  - BAX
  - BAK1
  - MCL1
  - BCL2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - BTK
  - PLCG1
  - PLCG2
  - AKT1
  - AKT2
  - AKT3
  - MAP3K14
  - MAP4K4
  - PRKCB
  - MTOR
  - CHUK
  - IKBKG
  - CUX1
  - NFKB2
  - OAS3
  - PMEL
  - SART3
  - TPX2
  - SND1
  - ASCC2
  - RELB
  - IKBKB
  - ARHGEF7
  - ASCC1
  - H3P40
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - FKBP4
  - GTF2H4
  - PMPCB
  - PSIP1
  - H3P42
  - CDK6
  - CDK4
  - CDKN2A
  - H3P10
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - ATM
  - CHEK1
  - CHEK2
  - DCLK1
  - ADGRL1
  - CLU
  - AKR1C4
  - GZMB
  - POLR3K
  - TP53
  - TP63
  - TP73
  - MDM4
  - MDM2
  - Cancer
---
